Soligenix, Inc. Common Stock — Quarterly Financial Statements (NASDAQ:SNGX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 5.109 M
Employee 16
Founded 1987
CEO N/A
Website www.soligenix.com
Headquarter Delaware, United States
FIGI BBG000FVMHG5
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

5.11 M Market capitalization

Price to earnings ratio

-0.48

Price to sales ratio

-345

Dividends per share

—

Dividend yield %

—

Haberler

Soligenix, Behçet Hastalığı için yetim ilaç statüsü aldı

Soligenix receives positive EMA opinion for orphan drug status